Rujia Xie

Rujia Xie, Ph.D.

Joined Pharmetheus in 2024, actively working in client projects
Expertise includes pharmacometrics in early and late phase projects in therapeutic areas such as infectious, neuropathic pain, inflammation & immunology, and pediatric drug development
Previously worked as Director in Pharmacometrics at Pfizer Singapore, where she led MIDD strategy, performed analyses, and supported filings for Pfizer global projects, as Head of Pharmacometrics at Pfizer China R&D, as Associate Director/Manager in Pharmacometrics at Pfizer, UK, and as Associate Professor/Assistant Professor/Teaching Assistant at China Pharmaceutical University, China
B.Sc in Pharmacy (1983) from Nanjing University of TCM, China, and Ph.D. in Pharmacokinetics (2000) from Uppsala University, Sweden